{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T13:54:45Z","timestamp":1790949285996,"version":"4.1.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T00:00:00Z","timestamp":1783555200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T00:00:00Z","timestamp":1790899200000},"content-version":"vor","delay-in-days":85,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82171190"],"award-info":[{"award-number":["82171190"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"publisher","award":["BE2018778"],"award-info":[{"award-number":["BE2018778"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009156","name":"Nantong Science and Technology Bureau","doi-asserted-by":"publisher","award":["MS22021010"],"award-info":[{"award-number":["MS22021010"]}],"id":[{"id":"10.13039\/501100009156","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Discov."],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Breast cancer (BC) remains the most prevalent malignancy among women worldwide, with persistent challenges such as drug resistance and tumor progression despite significant therapeutic advancements. The roles of ferroptosis and long non-coding RNAs (lncRNAs) in BC are not yet fully elucidated, underscoring the need for novel therapeutic targets. In this study, we investigated the function of LINC01929 in BC through a combination of in vitro and in vivo experiments, bioinformatics analysis, RNA pull-down mass spectrometry, and clinical tissue validation. We found that LINC01929 is significantly overexpressed in BC tissues and is associated with poor patient prognosis. Mechanistically, LINC01929 promoted malignant phenotypes in BC cells and was associated with reduced ferroptosis-related stress, with these effects being at least partly dependent on transferrin receptor (TFRC). Conversely, silencing LINC01929 led to reduced TFRC expression and induced ferroptosis in BC cells. Clinical data further confirmed that elevated TFRC levels correlate with aggressive tumor features and unfavorable outcomes. These findings suggest that targeting LINC01929 to regulate TFRC-mediated ferroptosis could represent a promising therapeutic strategy for BC, positioning both LINC01929 and TFRC as potential biomarkers and therapeutic targets.<\/jats:p>","DOI":"10.1038\/s41420-026-03248-y","type":"journal-article","created":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T07:05:10Z","timestamp":1783580710000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["LINC01929 promotes breast cancer progression through a TFRC-associated ferroptosis pathway"],"prefix":"10.1038","volume":"12","author":[{"given":"Gang","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijun","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongmei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianglin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianjiao","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisha","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongmei","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4810-8534","authenticated-orcid":false,"given":"Guohua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,9]]},"reference":[{"key":"3248_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229\u201363.","journal-title":"CA Cancer J Clin"},{"key":"3248_CR2","first-page":"409","volume":"72","author":"KD Miller","year":"2022","unstructured":"Miller KD, Nogueira L, Devasia T, Mariotto AB, Yabroff KR, Jemal A, et al. Cancer treatment and survivorship statistics, 2022. CA Cancer J Clin. 2022;72:409\u201336.","journal-title":"CA Cancer J Clin"},{"key":"3248_CR3","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/s41580-020-00315-9","volume":"22","author":"L Statello","year":"2021","unstructured":"Statello L, Guo CJ, Chen LL, Huarte M. Gene regulation by long non-coding RNAs and its biological functions. Nat Rev Mol Cell Biol. 2021;22:96\u2013118.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"3248_CR4","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s13058-020-01345-z","volume":"22","author":"C Fumagalli","year":"2020","unstructured":"Fumagalli C, Ranghiero A, Gandini S, Corso F, Taormina S, De Camilli E, et al. Inter-tumor genomic heterogeneity of breast cancers: comprehensive genomic profile of primary early breast cancers and relapses. Breast Cancer Res. 2020;22:107.","journal-title":"Breast Cancer Res"},{"key":"3248_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2021.114811","volume":"195","author":"D Rosati","year":"2022","unstructured":"Rosati D, Giordano A. Single-cell RNA sequencing and bioinformatics as tools to decipher cancer heterogenicity and mechanisms of drug resistance. Biochem Pharmacol. 2022;195:114811.","journal-title":"Biochem Pharmacol"},{"key":"3248_CR6","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-022-01578-w","volume":"21","author":"K Yuan","year":"2022","unstructured":"Yuan K, Lan J, Xu L, Feng X, Liao H, Xie K, et al. Long noncoding RNA TLNC1 promotes the growth and metastasis of liver cancer via inhibition of p53 signaling. Mol Cancer. 2022;21:105.","journal-title":"Mol Cancer"},{"key":"3248_CR7","doi-asserted-by":"publisher","first-page":"2380","DOI":"10.1016\/j.cmet.2021.11.011","volume":"33","author":"MK Park","year":"2021","unstructured":"Park MK, Zhang L, Min KW, Cho JH, Yeh CC, Moon H, et al. NEAT1 is essential for metabolic changes that promote breast cancer growth and metastasis. Cell Metab. 2021;33:2380\u201397.e9.","journal-title":"Cell Metab"},{"key":"3248_CR8","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1038\/s41419-021-04296-1","volume":"12","author":"W Luo","year":"2021","unstructured":"Luo W, Wang J, Xu W, Ma C, Wan F, Huang Y, et al. LncRNA RP11-89 facilitates tumorigenesis and ferroptosis resistance through PROM2-activated iron export by sponging miR-129-5p in bladder cancer. Cell Death Dis. 2021;12:1043.","journal-title":"Cell Death Dis"},{"key":"3248_CR9","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.ccell.2019.01.019","volume":"35","author":"R Esposito","year":"2019","unstructured":"Esposito R, Bosch N, Lanz\u00f3s A, Polidori T, Pulido-Quetglas C, Johnson R. Hacking the cancer genome: profiling therapeutically actionable long non-coding RNAs using CRISPR-Cas9 screening. Cancer Cell. 2019;35:545\u201357.","journal-title":"Cancer Cell"},{"key":"3248_CR10","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1038\/s41588-018-0252-3","volume":"50","author":"J Kim","year":"2018","unstructured":"Kim J, Piao HL, Kim BJ, Yao F, Han Z, Wang Y, et al. Long noncoding RNA MALAT1 suppresses breast cancer metastasis. Nat Genet. 2018;50:1705\u201315.","journal-title":"Nat Genet"},{"key":"3248_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/s40781-018-0183-7","volume":"60","author":"JK Dhanoa","year":"2018","unstructured":"Dhanoa JK, Sethi RS, Verma R, Arora JS, Mukhopadhyay CS. Long non-coding RNA: its evolutionary relics and biological implications in mammals: a review. J Anim Sci Technol. 2018;60:25.","journal-title":"J Anim Sci Technol"},{"key":"3248_CR12","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/s41568-020-00306-0","volume":"21","author":"GJ Goodall","year":"2021","unstructured":"Goodall GJ, Wickramasinghe VO. RNA in cancer. Nat Rev Cancer. 2021;21:22\u201336.","journal-title":"Nat Rev Cancer"},{"key":"3248_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.856560","volume":"12","author":"Y Xiong","year":"2022","unstructured":"Xiong Y, Pang M, Du Y, Yu X, Yuan J, Liu W, et al. The LINC01929\/miR-6875-5p\/ADAMTS12 axis in the ceRNA network regulates the development of advanced bladder cancer. Front Oncol. 2022;12:856560.","journal-title":"Front Oncol"},{"key":"3248_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.657876","volume":"11","author":"H Che","year":"2021","unstructured":"Che H, Che Y, Zhang Z, Lu Q. Long non-coding RNA LINC01929 accelerates progression of oral squamous cell carcinoma by targeting the miR-137-3p\/FOXC1 axis. Front Oncol. 2021;11:657876.","journal-title":"Front Oncol"},{"key":"3248_CR15","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","volume":"22","author":"X Jiang","year":"2021","unstructured":"Jiang X, Stockwell BR, Conrad M. Ferroptosis: mechanisms, biology and role in disease. Nat Rev Mol Cell Biol. 2021;22:266\u201382.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"3248_CR16","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.canlet.2020.02.015","volume":"483","author":"Y Su","year":"2020","unstructured":"Su Y, Zhao B, Zhou L, Zhang Z, Shen Y, Lv H, et al. Ferroptosis, a novel pharmacological mechanism of anti-cancer drugs. Cancer Lett. 2020;483:127\u201336.","journal-title":"Cancer Lett"},{"key":"3248_CR17","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/s41568-022-00459-0","volume":"22","author":"G Lei","year":"2022","unstructured":"Lei G, Zhuang L, Gan B. Targeting ferroptosis as a vulnerability in cancer. Nat Rev Cancer. 2022;22:381\u201396.","journal-title":"Nat Rev Cancer"},{"key":"3248_CR18","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202100997","volume":"8","author":"X Yao","year":"2021","unstructured":"Yao X, Li W, Fang D, Xiao C, Wu X, Li M, et al. Emerging roles of energy metabolism in ferroptosis regulation of tumor cells. Adv Sci. 2021;8:e2100997.","journal-title":"Adv Sci"},{"key":"3248_CR19","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1002\/cac2.12250","volume":"42","author":"L Zhao","year":"2022","unstructured":"Zhao L, Zhou X, Xie F, Zhang L, Yan H, Huang J, et al. Ferroptosis in cancer and cancer immunotherapy. Cancer Commun. 2022;42:88\u2013116.","journal-title":"Cancer Commun"},{"key":"3248_CR20","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1016\/j.molmed.2021.06.014","volume":"27","author":"H Xu","year":"2021","unstructured":"Xu H, Ye D, Ren M, Zhang H, Bi F. Ferroptosis in the tumor microenvironment: perspectives for immunotherapy. Trends Mol Med. 2021;27:856\u201367.","journal-title":"Trends Mol Med"},{"key":"3248_CR21","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43:e47.","journal-title":"Nucleic Acids Res"},{"key":"3248_CR22","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1038\/s41392-022-01046-3","volume":"7","author":"W Gao","year":"2022","unstructured":"Gao W, Wang X, Zhou Y, Wang X, Yu Y. Autophagy, ferroptosis, pyroptosis, and necroptosis in tumor immunotherapy. Signal Transduct Target Ther. 2022;7:196.","journal-title":"Signal Transduct Target Ther"},{"key":"3248_CR23","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1038\/s41556-019-0311-8","volume":"21","author":"RW Yao","year":"2019","unstructured":"Yao RW, Wang Y, Chen LL. Cellular functions of long noncoding RNAs. Nat Cell Biol. 2019;21:542\u201351.","journal-title":"Nat Cell Biol"},{"key":"3248_CR24","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.semcancer.2020.12.012","volume":"75","author":"EM McCabe","year":"2021","unstructured":"McCabe EM, Rasmussen TP. lncRNA involvement in cancer stem cell function and epithelial-mesenchymal transitions. Semin Cancer Biol. 2021;75:38\u201348.","journal-title":"Semin Cancer Biol"},{"key":"3248_CR25","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1038\/s41418-019-0304-y","volume":"26","author":"M Wang","year":"2019","unstructured":"Wang M, Mao C, Ouyang L, Liu Y, Lai W, Liu N, et al. Long noncoding RNA LINC00336 inhibits ferroptosis in lung cancer by functioning as a competing endogenous RNA. Cell Death Differ. 2019;26:2329\u201343.","journal-title":"Cell Death Differ"},{"key":"3248_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2023.100936","volume":"68","author":"X Qu","year":"2023","unstructured":"Qu X, Liu B, Wang L, Liu L, Zhao W, Liu C, et al. Loss of cancer-associated fibroblast-derived exosomal DACT3-AS1 promotes malignant transformation and ferroptosis-mediated oxaliplatin resistance in gastric cancer. Drug Resist Updat. 2023;68:100936.","journal-title":"Drug Resist Updat"},{"key":"3248_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-52837-8","volume":"9","author":"W Qi","year":"2019","unstructured":"Qi W, Li Z, Xia L, Dai J, Zhang Q, Wu C, et al. LncRNA GABPB1-AS1 and GABPB1 regulate oxidative stress during erastin-induced ferroptosis in HepG2 hepatocellular carcinoma cells. Sci Rep. 2019;9:16185.","journal-title":"Sci Rep"},{"key":"3248_CR28","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.cell.2013.12.010","volume":"156","author":"WS Yang","year":"2014","unstructured":"Yang WS, SriRamaratnam R, Welsch ME, Shimada K, Skouta R, Viswanathan VS, et al. Regulation of ferroptotic cancer cell death by GPX4. Cell. 2014;156:317\u201331.","journal-title":"Cell"},{"key":"3248_CR29","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/bs.pmbts.2022.06.019","volume":"194","author":"SC Moharir","year":"2023","unstructured":"Moharir SC, Sirohi K, Swarup G. Regulation of transferrin receptor trafficking by optineurin and its disease-associated mutants. Prog Mol Biol Transl Sci. 2023;194:67\u201378.","journal-title":"Prog Mol Biol Transl Sci"},{"key":"3248_CR30","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.immuni.2020.07.017","volume":"53","author":"HQ Dinh","year":"2020","unstructured":"Dinh HQ, Eggert T, Meyer MA, Zhu YP, Olingy CE, Llewellyn R, et al. Coexpression of CD71 and CD117 identifies an early unipotent neutrophil progenitor population in human bone marrow. Immunity. 2020;53:319\u201334.e6.","journal-title":"Immunity"},{"key":"3248_CR31","doi-asserted-by":"publisher","first-page":"3164","DOI":"10.1073\/pnas.1422373112","volume":"112","author":"S Lakhal-Littleton","year":"2015","unstructured":"Lakhal-Littleton S, Wolna M, Carr CA, Miller JJ, Christian HC, Ball V, et al. Cardiac ferroportin regulates cellular iron homeostasis and is important for cardiac function. Proc Natl Acad Sci USA. 2015;112:3164\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3248_CR32","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.molcel.2015.06.011","volume":"59","author":"M Gao","year":"2015","unstructured":"Gao M, Monian P, Quadri N, Ramasamy R, Jiang X. Glutaminolysis and transferrin regulate ferroptosis. Mol Cell. 2015;59:298\u2013308.","journal-title":"Mol Cell"},{"key":"3248_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2024.133323","volume":"274","author":"J Qin","year":"2024","unstructured":"Qin J, Li Z, Su L, Wen X, Tang X, Huang M, et al. Expression of transferrin receptor\/TFRC protein in bladder cancer cell T24 and its role in inducing iron death in bladder cancer. Int J Biol Macromol. 2024;274:133323.","journal-title":"Int J Biol Macromol"},{"key":"3248_CR34","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1126\/science.1157643","volume":"320","author":"H Shi","year":"2008","unstructured":"Shi H, Bencze KZ, Stemmler TL, Philpott CC. A cytosolic iron chaperone that delivers iron to ferritin. Science. 2008;320:1207\u201310.","journal-title":"Science"},{"key":"3248_CR35","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.freeradbiomed.2018.06.037","volume":"133","author":"H Kawabata","year":"2019","unstructured":"Kawabata H. Transferrin and transferrin receptors update. Free Radic Biol Med. 2019;133:46\u201354.","journal-title":"Free Radic Biol Med"},{"key":"3248_CR36","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2022.756895","volume":"9","author":"C Yang","year":"2022","unstructured":"Yang C, Li J, Guo Y, Gan D, Zhang C, Wang R, et al. Role of TFRC as a novel prognostic biomarker and in immunotherapy for pancreatic carcinoma. Front Mol Biosci. 2022;9:756895.","journal-title":"Front Mol Biosci"},{"key":"3248_CR37","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/685396","volume":"2014","author":"R Parenti","year":"2014","unstructured":"Parenti R, Salvatorelli L, Magro G. Anaplastic thyroid carcinoma: current treatments and potential new therapeutic options with emphasis on TfR1\/CD71. Int J Endocrinol. 2014;2014:685396.","journal-title":"Int J Endocrinol"},{"key":"3248_CR38","doi-asserted-by":"publisher","first-page":"e0182954","DOI":"10.1371\/journal.pone.0182954","volume":"12","author":"AM Rosager","year":"2017","unstructured":"Rosager AM, S\u00f8rensen MD, Dahlrot RH, Hansen S, Schonberg DL, Rich JN, et al. Transferrin receptor-1 and ferritin heavy and light chains in astrocytic brain tumors: expression and prognostic value. PLoS ONE. 2017;12:e0182954.","journal-title":"PLoS ONE"},{"key":"3248_CR39","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.1016\/j.ymthe.2021.03.022","volume":"29","author":"H Wang","year":"2021","unstructured":"Wang H, Cheng Y, Mao C, Liu S, Xiao D, Huang J, et al. Emerging mechanisms and targeted therapy of ferroptosis in cancer. Mol Ther. 2021;29:2185\u2013208.","journal-title":"Mol Ther"},{"key":"3248_CR40","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/s41571-020-00462-0","volume":"18","author":"X Chen","year":"2021","unstructured":"Chen X, Kang R, Kroemer G, Tang D. Broadening horizons: the role of ferroptosis in cancer. Nat Rev Clin Oncol. 2021;18:280\u201396.","journal-title":"Nat Rev Clin Oncol"},{"key":"3248_CR41","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.686906","volume":"9","author":"Y Zhi","year":"2021","unstructured":"Zhi Y, Gao L, Wang B, Ren W, Liang KX, Zhi K. Ferroptosis holds novel promise in treatment of cancer mediated by non-coding RNAs. Front Cell Dev Biol. 2021;9:686906.","journal-title":"Front Cell Dev Biol"},{"key":"3248_CR42","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s10549-021-06501-3","volume":"193","author":"L Qi","year":"2022","unstructured":"Qi L, Sun B, Yang B, Lu S. PGM5P3-AS1 regulates MAP1LC3C to promote cell ferroptosis and thus inhibiting the malignant progression of triple-negative breast cancer. Breast Cancer Res Treat. 2022;193:305\u201318.","journal-title":"Breast Cancer Res Treat"},{"key":"3248_CR43","doi-asserted-by":"publisher","first-page":"153303382311643","DOI":"10.1177\/15330338231164359","volume":"22","author":"C Zhang","year":"2023","unstructured":"Zhang C, Xu L, Li X, Chen Y, Shi T, Wang Q. LINC00460 facilitates cell proliferation and inhibits ferroptosis in breast cancer through the miR-320a\/MAL2 axis. Technol Cancer Res Treat. 2023;22:15330338231164359.","journal-title":"Technol Cancer Res Treat"},{"key":"3248_CR44","doi-asserted-by":"publisher","first-page":"215","DOI":"10.2217\/epi-2023-0100","volume":"16","author":"J Li","year":"2024","unstructured":"Li J, Li PT, Wu W, Ding BN, Wen YG, Cai HL, et al. POU2F2-mediated upregulation of lncRNA PTPRG-AS1 inhibits ferroptosis in breast cancer via miR-376c-3p\/SLC7A11 axis. Epigenomics. 2024;16:215\u201331.","journal-title":"Epigenomics"},{"key":"3248_CR45","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1007\/s12672-023-00652-z","volume":"14","author":"S Wang","year":"2023","unstructured":"Wang S, Wang Y, Li Q, Zeng K, Li X, Feng X. RUNX1-IT1 favors breast cancer carcinogenesis through regulation of IGF2BP1\/GPX4 axis. Discov Oncol. 2023;14:42.","journal-title":"Discov Oncol"},{"key":"3248_CR46","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1111\/jcmm.13008","volume":"21","author":"H Yu","year":"2017","unstructured":"Yu H, Guo P, Xie X, Wang Y, Chen G. Ferroptosis, a new form of cell death, and its relationships with tumourous diseases. J Cell Mol Med. 2017;21:648\u201357.","journal-title":"J Cell Mol Med"},{"key":"3248_CR47","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-19213-4","volume":"8","author":"M Sato","year":"2018","unstructured":"Sato M, Kusumi R, Hamashima S, Kobayashi S, Sasaki S, Komiyama Y, et al. The ferroptosis inducer erastin irreversibly inhibits system x(c)- and synergizes with cisplatin to increase cisplatin\u2019s cytotoxicity in cancer cells. Sci Rep. 2018;8:968.","journal-title":"Sci Rep"},{"key":"3248_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2022.102493","volume":"57","author":"J Zhang","year":"2022","unstructured":"Zhang J, Chen S, Wei S, Cheng S, Shi R, Zhao R, et al. CircRAPGEF5 interacts with RBFOX2 to confer ferroptosis resistance by modulating alternative splicing of TFRC in endometrial cancer. Redox Biol. 2022;57:102493.","journal-title":"Redox Biol"},{"key":"3248_CR49","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s13045-024-01599-6","volume":"17","author":"J Wang","year":"2024","unstructured":"Wang J, Xiu M, Wang J, Gao Y, Li Y. METTL16-SENP3-LTF axis confers ferroptosis resistance and facilitates tumorigenesis in hepatocellular carcinoma. J Hematol Oncol. 2024;17:78.","journal-title":"J Hematol Oncol"},{"key":"3248_CR50","doi-asserted-by":"crossref","unstructured":"Gene Ontology Consortium. Gene Ontology Consortium: going forward. Nucleic Acids Res. 2015;43:D1049\u201356.","DOI":"10.1093\/nar\/gku1179"},{"key":"3248_CR51","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa M, Goto S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 2000;28:27\u201330.","journal-title":"Nucleic Acids Res"},{"key":"3248_CR52","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1007\/BF00300234","volume":"24","author":"MM Tomayko","year":"1989","unstructured":"Tomayko MM, Reynolds CP. Determination of subcutaneous tumor size in athymic (nude) mice. Cancer Chemother Pharmacol. 1989;24:148\u201354.","journal-title":"Cancer Chemother Pharmacol"},{"key":"3248_CR53","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1093\/ilar.43.4.207","volume":"43","author":"RB Dell","year":"2002","unstructured":"Dell RB, Holleran S, Ramakrishnan R. Sample size determination. ILAR J. 2002;43:207\u201313.","journal-title":"ILAR J"}],"container-title":["Cell Death Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41420-026-03248-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41420-026-03248-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41420-026-03248-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T13:02:23Z","timestamp":1790946143000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41420-026-03248-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,9]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3248"],"URL":"https:\/\/doi.org\/10.1038\/s41420-026-03248-y","relation":{},"ISSN":["2058-7716"],"issn-type":[{"value":"2058-7716","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,9]]},"assertion":[{"value":"25 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"The study protocol was reviewed and approved by the Ethics Committee of the Affiliated Hospital of Nantong University, China (Approval No. 2024-K063-01). Written informed consent was obtained from all participants or their legally authorized representatives prior to enrollment. All murine experiments were reviewed and approved by the Animal Ethics Committee of Nantong University (Approval No. S20221115-902) and were conducted in accordance with institutional guidelines for the care and use of laboratory animals.","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"396"}}